Integrated single-cell and bulk RNA-Seq analysis enhances prognostic accuracy of PD-1/PD-L1 immunotherapy response in lung adenocarcinoma through necroptotic anoikis gene signatures

In addition to presenting significant diagnostic and treatment challenges, lung adenocarcinoma (LUAD) is the most common form of lung cancer. Using scRNA-Seq and bulk RNA-Seq data, we identify three genes referred to as HMR, FAM83A, and KRT6A these genes are related to necroptotic anoikis-related ge...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Sui, Ping (VerfasserIn) , Liu, Xueping (VerfasserIn) , Zhong, Cheng (VerfasserIn) , Sha, Zhanming (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 13 May 2024
In: Scientific reports
Year: 2024, Jahrgang: 14, Pages: 1-17
ISSN:2045-2322
DOI:10.1038/s41598-024-61629-8
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41598-024-61629-8
Verlag, kostenfrei, Volltext: https://www.nature.com/articles/s41598-024-61629-8
Volltext
Verfasserangaben:Ping Sui, Xueping Liu, Cheng Zhong & Zhanming Sha

MARC

LEADER 00000caa a2200000 c 4500
001 190930543X
003 DE-627
005 20241205222029.0
007 cr uuu---uuuuu
008 241121s2024 xx |||||o 00| ||eng c
024 7 |a 10.1038/s41598-024-61629-8  |2 doi 
035 |a (DE-627)190930543X 
035 |a (DE-599)KXP190930543X 
035 |a (OCoLC)1475647774 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Sui, Ping  |e VerfasserIn  |0 (DE-588)1348907908  |0 (DE-627)190930591X  |4 aut 
245 1 0 |a Integrated single-cell and bulk RNA-Seq analysis enhances prognostic accuracy of PD-1/PD-L1 immunotherapy response in lung adenocarcinoma through necroptotic anoikis gene signatures  |c Ping Sui, Xueping Liu, Cheng Zhong & Zhanming Sha 
246 3 0 |a one 
264 1 |c 13 May 2024 
300 |b Illustrationen 
300 |a 17 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 21.11.2024 
520 |a In addition to presenting significant diagnostic and treatment challenges, lung adenocarcinoma (LUAD) is the most common form of lung cancer. Using scRNA-Seq and bulk RNA-Seq data, we identify three genes referred to as HMR, FAM83A, and KRT6A these genes are related to necroptotic anoikis-related gene expression. Initial validation, conducted on the GSE50081 dataset, demonstrated the model's ability to categorize LUAD patients into high-risk and low-risk groups with significant survival differences. This model was further applied to predict responses to PD-1/PD-L1 blockade therapies, utilizing the IMvigor210 and GSE78220 cohorts, and showed strong correlation with patient outcomes, highlighting its potential in personalized immunotherapy. Further, LUAD cell lines were analyzed using quantitative PCR (qPCR) and Western blot analysis to confirm their expression levels, further corroborating the model's relevance in LUAD pathophysiology. The mutation landscape of these genes was also explored, revealing their broad implication in various cancer types through a pan-cancer analysis. The study also delved into molecular subclustering, revealing distinct expression profiles and associations with different survival outcomes, emphasizing the model’s utility in precision oncology. Moreover, the diversity of immune cell infiltration, analyzed in relation to the necroptotic anoikis signature, suggested significant implications for immune evasion mechanisms in LUAD. While the findings present a promising stride towards personalized LUAD treatment, especially in immunotherapy, limitations such as the retrospective nature of the datasets and the need for larger sample sizes are acknowledged. Prospective clinical trials and further experimental research are essential to validate these findings and enhance the clinical applicability of our prognostic model. 
650 4 |a Cancer 
650 4 |a Cell biology 
650 4 |a Diseases 
650 4 |a Genetics 
650 4 |a Immunology 
700 1 |a Liu, Xueping  |e VerfasserIn  |4 aut 
700 1 |a Zhong, Cheng  |e VerfasserIn  |4 aut 
700 1 |a Sha, Zhanming  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Scientific reports  |d [London] : Springer Nature, 2011  |g 14(2024), Artikel-ID 10873, Seite 1-17  |h Online-Ressource  |w (DE-627)663366712  |w (DE-600)2615211-3  |w (DE-576)346641179  |x 2045-2322  |7 nnas  |a Integrated single-cell and bulk RNA-Seq analysis enhances prognostic accuracy of PD-1/PD-L1 immunotherapy response in lung adenocarcinoma through necroptotic anoikis gene signatures 
773 1 8 |g volume:14  |g year:2024  |g elocationid:10873  |g pages:1-17  |g extent:17  |a Integrated single-cell and bulk RNA-Seq analysis enhances prognostic accuracy of PD-1/PD-L1 immunotherapy response in lung adenocarcinoma through necroptotic anoikis gene signatures 
856 4 0 |u https://doi.org/10.1038/s41598-024-61629-8  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/s41598-024-61629-8  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20241121 
993 |a Article 
994 |a 2024 
998 |g 1348907908  |a Sui, Ping  |m 1348907908:Sui, Ping  |p 1  |x j 
999 |a KXP-PPN190930543X  |e 4620384399 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"[London] ; London","dateIssuedDisp":"2011-","dateIssuedKey":"2011","publisher":"Springer Nature ; Nature Publishing Group"}],"id":{"zdb":["2615211-3"],"eki":["663366712"],"issn":["2045-2322"]},"pubHistory":["1, article number 1 (2011)-"],"part":{"volume":"14","text":"14(2024), Artikel-ID 10873, Seite 1-17","extent":"17","year":"2024","pages":"1-17"},"note":["Gesehen am 12.07.24"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Integrated single-cell and bulk RNA-Seq analysis enhances prognostic accuracy of PD-1/PD-L1 immunotherapy response in lung adenocarcinoma through necroptotic anoikis gene signaturesScientific reports","language":["eng"],"recId":"663366712","title":[{"title":"Scientific reports","title_sort":"Scientific reports"}]}],"physDesc":[{"noteIll":"Illustrationen","extent":"17 S."}],"name":{"displayForm":["Ping Sui, Xueping Liu, Cheng Zhong & Zhanming Sha"]},"id":{"doi":["10.1038/s41598-024-61629-8"],"eki":["190930543X"]},"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"13 May 2024"}],"recId":"190930543X","language":["eng"],"note":["Gesehen am 21.11.2024"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"family":"Sui","given":"Ping","roleDisplay":"VerfasserIn","display":"Sui, Ping","role":"aut"},{"family":"Liu","given":"Xueping","display":"Liu, Xueping","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Cheng","family":"Zhong","role":"aut","roleDisplay":"VerfasserIn","display":"Zhong, Cheng"},{"family":"Sha","given":"Zhanming","roleDisplay":"VerfasserIn","display":"Sha, Zhanming","role":"aut"}],"title":[{"title_sort":"Integrated single-cell and bulk RNA-Seq analysis enhances prognostic accuracy of PD-1/PD-L1 immunotherapy response in lung adenocarcinoma through necroptotic anoikis gene signatures","title":"Integrated single-cell and bulk RNA-Seq analysis enhances prognostic accuracy of PD-1/PD-L1 immunotherapy response in lung adenocarcinoma through necroptotic anoikis gene signatures"}]} 
SRT |a SUIPINGLIUINTEGRATED1320